Suita, Japan

Naoki Hosen


 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Osaka, JP (2015)
  • Suita, JP (2020 - 2021)

Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Naoki Hosen: Innovator in Pharmaceutical Composition

Introduction

Naoki Hosen is a prominent inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of myeloma. With a total of 3 patents to his name, Hosen's work is recognized for its innovative approach to medical treatments.

Latest Patents

Hosen's latest patents focus on antibodies that serve as active ingredients in pharmaceutical compositions for treating myeloma. Specifically, he has developed an antibody whose epitope is present in the region of the amino acid residue positions 20 to 109 of human integrin β. This innovative approach aims to enhance the efficacy of treatments for patients suffering from this challenging condition.

Career Highlights

Naoki Hosen is affiliated with Osaka University, where he conducts his research and development. His work has garnered attention in the scientific community, contributing to advancements in medical therapies. Hosen's dedication to improving patient outcomes through innovative solutions is evident in his research endeavors.

Collaborations

Hosen collaborates with esteemed colleagues, including Haruo Sugiyama and Atsushi Kumanogoh. These partnerships enhance the research environment and foster the exchange of ideas, leading to groundbreaking advancements in the field.

Conclusion

Naoki Hosen's contributions to pharmaceutical innovations, particularly in the treatment of myeloma, highlight his role as a leading inventor in the medical field. His work continues to inspire advancements that may significantly impact patient care and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…